Kate Falberg

Board Member, Arcus Biosciences
San Francisco, California,United States
Find Kate Falberg's Email
Find Kate Falberg's Phone

Who Is Kate Falberg?

Total Experience35 years
CompanyArcus Biosciences
CountryUnited States

Kate Falberg is a highly accomplished executive and board member with extensive experience in the biotechnology and healthcare industries. She had a distinguished 18-year career at Amgen, a global biotechnology pioneer, where she held numerous senior executive positions, culminating in her role as Senior Vice President, Finance and Strategy, and Chief Financial Officer. During her tenure, she was instrumental in managing Amgen's financial growth, strategic planning, and significant M&A activities. After Amgen, Ms. Falberg co-founded Health Evolutions, Inc., a venture capital firm focused on investing in early-stage healthcare companies. She is a sought-after board member, lending her expertise in finance, corporate strategy, and governance to various public and private companies, primarily in the life sciences sector. Her leadership is characterized by a deep understanding of financial markets, operational scaling, and strategic value creation in complex, regulated industries.

How Did Kate Falberg's Career Path Shape Their Journey?

Kate Falberg's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Arcus Biosciences - Board Member(2017 to Present)
The Trade Desk, Inc. - Board Member(2016 to Present)
Nuvation Bio - Board Member(2020 to Present)
Medivation - Board Member(2013 to 2016)
Jazz Pharmaceuticals - EVP and CFO(2009 to 2014)
Amgen - Sr. V.P. Finance, Strategy and CFO(1995 to 2001)

What Are Kate Falberg's Key Achievements?

Chief Financial Officer at Amgen

Served as Senior Vice President, Finance and Strategy, and Chief Financial Officer at Amgen, overseeing the company's financial operations, strategic planning, and capital allocation during a period of substantial growth and global expansion.

Co-founder of Health Evolutions, Inc.

Co-founded Health Evolutions, a venture capital firm dedicated to identifying and nurturing innovative early-stage healthcare and life sciences companies, thereby contributing to advancements in medical technology and patient care.

Extensive Corporate Board Service

Has served on the boards of numerous publicly traded and private companies, including BioMarin Pharmaceutical, Adverum Biotechnologies, Medivation (acquired by Pfizer), Halozyme Therapeutics, and Guardant Health, providing critical financial oversight, strategic guidance, and governance.

Leadership in Strategic Transactions

Played a key role in numerous strategic transactions, including significant mergers, acquisitions, and capital market financings, throughout her career at Amgen and in her board roles.

What's Kate Falberg's Educational Background?

Master of Business Administration (MBA), Finance

University of California, Los Angeles - The Anderson School of Management - Year 1983

Bachelor of Arts (B.A.), Economics

University of California, Los Angeles - Year 1977

Buying Intent Signals for Kate Falberg

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Arcus Biosciences
Total employees591
HeadquartersHayward, California
Founded2015

Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies. They are developing a portfolio of novel product candidates that target critical biological pathways involved in tumor-immune evasion. Their approach includes both small molecule and antibody therapeutics designed to be used as monotherapies or in combination to address unmet needs in oncology.

Arcus Biosciences Stock Information
Arcus Biosciences, Inc. is listed on the NYSE under the ticker symbol RCUS. The company went public on March 15, 2018

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Thousands of companies, including, are just a search away.